Yahoo India Web Search

Search results

  1. 2 days ago · Akinori NAKATA Professor, International University of Health and Welfare, Tokyo, Japan Rusli Bin NORDIN Professor, Taylor’s University, Selangor, Malaysia Jun OJIMA Senior Researcher, Work Environment RG, JNIOSH Tsutomu OKUNO Former Director, Human Engineering & Risk Management RG, JNIOSH Teruhito OTSUKA Principal Senior

  2. 4 days ago · Akinori ICHIKAWA. ※外国籍選手は国籍または出身地. HomeGrown=ホームグロウン選手. (ホームグロウン制度とは) 前所属チーム. FC中井-湘南ベルマーレ小田原-星槎国際湘南校-横浜FC-ガイナーレ鳥取-横浜FC-ガンバ大阪. 選手スタッツ. 各選手のスタッツから、リーグ内順位が最も高い3つの項目を抽出しています. GK. チームプレー. 規律. ※ラベルは各項目でのリーグ内順位を表します。 (※10位までを表示) 今シーズン. 通算. 大会を選択する. 選手リンク. 遠藤 雅己. フェリペ メギオラーロ. 大亀 司. ンドカ ボニフェイス. 中村 拓海. ガブリエウ. 一覧へ. クラブ一覧に戻る.

  3. 4 days ago · Otsuka and Lundbeck announce FDA acceptance of sNDA filing for brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD) June 24, 2024. Otsuka Pharmaceutical.

  4. 4 days ago · Otsuka and Lundbeck’s CNS drug Rexulti has for the second time this year claimed the top spot as the leading TV drug ad spender. That’s according to the latest data out by real-time ad trackers...

  5. 4 days ago · Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder.

  6. 5 days ago · Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity: - manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases.

  7. People also ask

  8. 5 days ago · Latest Otsuka Holdings Co Ltd (4578:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.